Premium
This is an archive article published on December 27, 2021

Covaxin only vaccine for children of 15-18 yrs, can book slots on Cowin from Jan 1: Govt

🔴 The ministry also announced on Monday that the three priority groups of healthcare workers, frontline workers, and individuals older than 60 can receive their third "precautionary dose" 39 weeks after getting their second jab.

Covaxin only vaccine for children of 15-18 yrs, can book slots on Cowin from Jan 1: GovtA vaccination drive held at the East Delhi Lal Quarter market, in New Delhi, on Saturday. (Express Photo by Amit Mehra)

Ahead of the January 10 rollout of Covid-19 shots for teens, the Union Health Ministry has announced that Bharat Biotech’s Covaxin will be the only vaccine that will be administered to eligible recipients in the age group of 15-18 years.

The ministry also announced on Monday that the three priority groups of healthcare workers, frontline workers, and individuals older than 60 can receive their third “precautionary dose” 39 weeks after getting their second jab.

“As a matter of abundant precaution, for those Health Care Workers (HCWs) & Front Line Workers (FLWs) who have received two doses, another dose of Covid-19 vaccine would be provided from January 10, 2022. The prioritisation and sequencing of this precaution dose would be based on the completion of 9 months, i.e. 39 weeks, from the date of administration of second dose,” the ministry said.

Story continues below this ad

The decisions to vaccinate adolescents and administer a precautionary dose to vulnerable groups were taken in view of the recent global surge of coronavirus infections, detection of the new Omicron variant of the virus, scientific evidence, global practices, “and the inputs/suggestions of ‘Covid-19 Working Group of National Technical Advisory Group on Immunization (NTAGI)’ as well as of ‘Standing Technical Scientific Committee (STSC)’ of NTAGI”, the ministry said.

Children born in 2007 and earlier shall be eligible to receive the vaccine, the ministry said. “…Vaccination of children in the age-group of 15-18 years to be started from January 3, 2022. For such beneficiaries, the vaccination option would be ‘Covaxin’ only,” the guidelines said.

Beneficiaries can register online through an existing account on Co-WIN, or after creating a new account through a unique mobile number. Children can book a slot using their parents’ existing Co-WIN accounts.

Dr R S Sharma, CEO, National Health Authority (NHA), which has designed the Co-WIN infrastructure, told The Indian Express that booking of slots for children will open from January 1. “The students can use the nine documents that are already listed (for adult vaccination). Additionally, they can also use their student identity cards,” Sharma said.

Story continues below this ad

The health ministry’s guidelines said children could be registered onsite by the verifier/vaccinator in facilitated registration mode; appointments can also be booked online or onsite (walk-in).

For the precautionary doses, the Co-WIN system will send SMSes to beneficiaries when the dose becomes due.

The precautionary dose will be administered on the advice of a doctor based on the comorbidity, the guidelines state. Sharma said the beneficiary will have to carry the certificate of comorbidity to the vaccination centre.

“The beneficiary will only be asked if they have comorbidity or not. They will just need to carry it to the vaccination centre. There is no need to upload anything before booking the slot on the Co-WIN platform,” he said.

Story continues below this ad

For the precautionary dose, registration and appointment services can be accessed through both online and onsite modes. “The details of administration of the precaution dose will be suitably reflected in the vaccination certificates,” the guidelines state.

While all citizens irrespective of income will be entitled to free vaccination in the new phase, “those who have the ability to pay are encouraged to use private hospital’s vaccination centres”, according to the guidelines.

Kaunain Sheriff M is an award-winning investigative journalist and the National Health Editor at The Indian Express. He is the author of Johnson & Johnson Files: The Indian Secrets of a Global Giant, an investigation into one of the world’s most powerful pharmaceutical companies. With over a decade of experience, Kaunain brings deep expertise in three areas of investigative journalism: law, health, and data. He currently leads The Indian Express newsroom’s in-depth coverage of health. His work has earned some of the most prestigious honours in journalism, including the Ramnath Goenka Award for Excellence in Journalism, the Society of Publishers in Asia (SOPA) Award, and the Mumbai Press Club’s Red Ink Award. Kaunain has also collaborated on major global investigations. He was part of the Implant Files project with the International Consortium of Investigative Journalists (ICIJ), which exposed malpractices in the medical device industry across the world. He also contributed to an international investigation that uncovered how a Chinese big-data firm was monitoring thousands of prominent Indian individuals and institutions in real time. Over the years, he has reported on several high-profile criminal trials, including the Hashimpura massacre, the 2G spectrum scam, and the coal block allocation case. Within The Indian Express, he has been honoured three times with the Indian Express Excellence Award for his investigations—on the anti-Sikh riots, the Vyapam exam scam, and the abuse of the National Security Act in Uttar Pradesh. ... Read More

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Loading Taboola...
Advertisement